Skip to content

Post-DES FFR predicts the clinical outcomes: DK CRUSH-VII, A Prospective, Multicenter, Registry Study

Post-DES FFR predicts the clinical outcomes: DK CRUSH-VII, A Prospective, Multicenter, Registry Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRCH-12001976
Enrollment
Unknown
Registered
2012-02-21
Start date
2012-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Group 1:FFR reach the standard
Group 2:FFR not reach the standard

Sponsors

Nanjing First Hospital, Nanjing Medical Univeristy
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. subjects aged 18-80 years old; 2. subjects (or legal guardian) understands the trial requirements and treatment procedures and provides written informed consent before any trial-specific tests or procedures are performed; 3. subjects is eligible for percutaneous coronary intervention (PCI); 4. subjects has Stable/unstable angina; 5. Non-infarct-related artery of subjects has STEMI>24-hour from the onset of chest pain to admission; 6. subjects is an acceptable candidate for coronary artery bypass grafting (CABG); 7. subjects is willing to comply with all protocol-required follow-up evaluations.

Exclusion criteria

Exclusion criteria: 1. Subjects with STEMI (within 24-hour from the onset of chest pain to admission); 2. Subjects suffering from atrial fibrillation; 3. Subjects has known allergy to the study stent system (everolimus) or protocol-required concomitant medications; 4. Subjects has any other serious medical illness that may reduce life expectancy to less than 12 months; 5. Subjects is a women who is pregnant or nursing; 6. Subjects has a planned procedure that may cause non-compliance with the protocol or confound data interpretation. Patient is participating in another clinical trial that has not reached its primary endpoint within 24 months after the index procedure; 7. Left main disease; 8. Severe calcification need Rotablator treatment; 9. Bridge vessels of coronary artery bypass graft (CABG).

Design outcomes

Primary

MeasureTime frame
Fractional flow reservation;

Countries

China

Contacts

Public ContactShaoliang Chen
chmengx@126.com+86 025 5227 1351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026